These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 21922202)
1. Prophylactic treatment of local reactions to i.v. vinorelbine: a randomized study. Quant E; Bergman B Support Care Cancer; 2012 Aug; 20(8):1737-44. PubMed ID: 21922202 [TBL] [Abstract][Full Text] [Related]
2. Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity. Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Saijo N; Nishiwaki Y Lung Cancer; 2007 Mar; 55(3):337-41. PubMed ID: 17126951 [TBL] [Abstract][Full Text] [Related]
3. Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation. Ibrahim NK; Valero V; Rahman Z; Theriault RL; Walters RS; Buzdar AU; Booser DJ; Holmes FA; Murray JL; Willey J; Bast R; Hortobagyi GN Cancer Invest; 2001; 19(5):459-66. PubMed ID: 11458813 [TBL] [Abstract][Full Text] [Related]
4. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma]. Bartsch V Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241 [TBL] [Abstract][Full Text] [Related]
5. Treatment of vinorelbine-associated tumor pain. Long TD; Twillman RK; Cathers-Schiffman TA; O'Donnell T Am J Clin Oncol; 2001 Aug; 24(4):414-5. PubMed ID: 11474276 [TBL] [Abstract][Full Text] [Related]
6. Vinorelbine and venous irritation: optimal parenteral administration. de Lemos ML J Oncol Pharm Pract; 2005 Jun; 11(2):79-81. PubMed ID: 16460608 [TBL] [Abstract][Full Text] [Related]
7. A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma. Feun LG; Savaraj N; Hurley J; Marini A; Lai S Cancer; 2000 Feb; 88(3):584-8. PubMed ID: 10649251 [TBL] [Abstract][Full Text] [Related]
8. Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study. Carabante-Ocón F; Cobo-Dols M; Benavides-Orgaz M; Gil-Calle S; Alés-Díaz I; Bretón-García JJ; Villar-Chamorro E; Montesa-Pino A; Alcalde-García J; Gutiérrez-Calderón V Clin Lung Cancer; 2005 Sep; 7(2):121-6. PubMed ID: 16179099 [TBL] [Abstract][Full Text] [Related]
9. A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients. Jassem J; Ramlau R; Karnicka-Młodkowska H; Krawczyk K; Krzakowski M; Zatloukal P; Lemarié E; Hartmann W; Novakova L; O'Brien M; Depierr A Ann Oncol; 2001 Oct; 12(10):1375-81. PubMed ID: 11762807 [TBL] [Abstract][Full Text] [Related]
10. [Acute pain at tumor recurrence site induced by vinorelbine infusion]. Shibahara H; Hiramatsu Y Kyobu Geka; 2013 Jul; 66(7):567-9. PubMed ID: 23917136 [TBL] [Abstract][Full Text] [Related]
11. Respiratory failure following vinorelbine tartrate infusion in a patient with non-small cell lung cancer. Kouroukis C; Hings I Chest; 1997 Sep; 112(3):846-8. PubMed ID: 9315826 [TBL] [Abstract][Full Text] [Related]
12. Ifosfamide and vinorelbine as first-line chemotherapy for advanced non-small cell lung carcinoma. Vallejo C; Romero A; Perez J; Cuevas M; Lacava J; Sabatini C; Dominguez M; Rodriguez R; Barbieri M; Romero Acuña L; Romero Acuña J; Langhi M; Amato S; Salvadori M; Ortiz E; Machiavelli M; Leone B Am J Clin Oncol; 1996 Dec; 19(6):584-8. PubMed ID: 8931677 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma. Ibrahim NK; Rahman Z; Valero V; Willey J; Theriault RL; Buzdar AU; Murray JL; Bast R; Hortobagyi GN Cancer; 1999 Oct; 86(7):1251-7. PubMed ID: 10506711 [TBL] [Abstract][Full Text] [Related]
14. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer: a phase I study. Gridelli C; Guida C; Barletta E; Gatani T; Fiore F; Barzelloni ML; Rossi A; de Bellis M; D'Aniello R; Scognamiglio F Lung Cancer; 2000 Aug; 29(2):131-7. PubMed ID: 10963843 [TBL] [Abstract][Full Text] [Related]
15. Skin necrosis from extravasation of vinorelbine. Moreno de Vega MJ; Dauden E; Abajo P; Bartolome B; Fraga J; Garcia-Diez A J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):488-90. PubMed ID: 12428844 [TBL] [Abstract][Full Text] [Related]
16. Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits. Kohno E; Murase S; Nishikata M; Okamura N; Matzno S; Kuwahara T; Matsuyama K Int J Med Sci; 2008 Jul; 5(4):218-23. PubMed ID: 18695742 [TBL] [Abstract][Full Text] [Related]
17. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine. Hoff PM; Valero V; Ibrahim N; Willey J; Hortobagyi GN Cancer; 1998 Mar; 82(5):965-9. PubMed ID: 9486588 [TBL] [Abstract][Full Text] [Related]